Wordt geladen...
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
Autologous chimeric antigen receptor (CAR) T cells targeted to epidermal growth factor receptor variant III (CAR T-EGFRvIII) have been developed and administered experimentally to treat patients with IDH1 wildtype recurrent glioblastoma (rGBM) (NCT02209376). We report the case of a 59-year-old patie...
Bewaard in:
| Gepubliceerd in: | Front Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138201/ https://ncbi.nlm.nih.gov/pubmed/34026647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.669071 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|